Access
To read this story in full you will need to login or make a payment (see right).
Outlook
Nature 449, 160-163 (13 September 2007) | doi:10.1038/449160a; Published online 12 September 2007
Neglected Diseases A tough transition
Peter A. Singer1, Kathryn Berndtson1, C. Shawn Tracy1, Emma R. M. Cohen1, Hassan Masum1, James V. Lavery2 & Abdallah S. Daar1
Top of page
Abstract
What is holding back biotechnology in the developing world? Peter A. Singer and his colleagues listen to those on the ground.
The path from basic scientific discovery to effective therapy is rarely rapid or simple, especially in the developing world. Making this transition easier is a sizeable and pressing problem.
To read this story in full you will need to login or make a payment (see right).